Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

5524.5000 29.50 (0.54%)

NSE Sep 23, 2025 09:25 AM

Volume: 10,606

Alkem Laboratories Ltd.

08 Feb 2025

5524.50

0.54%

Alkem Labs (SELL): Slower growth in a seasonally strong quarter

Sell: Alkem Laboratories Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Domestic sales were 6% below our estimates mainly due to slower recovery in the acute therapies and no price hike in NLEM portfolio

Alkem Laboratories Ltd. is trading above all available SMAs